IP Library › Granted Patent US 10,369,254
Granted Patent B2
US 10,369,254 · App. 15/121,551 · Granted Aug 6, 2019

Method and apparatus for in vitro kidney organogenesis

Inventors: Norimoto Yanagawa (Pacific Palisades, CA); Masaki Nishikawa (Van Nuys, CA); Morgan Hamon (Northridge, CA); Peter Viktor Hauser (Los Angeles, CA)
Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; U.S. DEPARTMENT OF VETERANS AFFAIRS
A61L27/3604A61L27/3683C12M21/08C12M23/16C12M23/58C12M25/14C12N5/0697C12N2502/256
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,254
App. No.
15/121,551
Granted
Aug 6, 2019
Kind
B2
Abstract

The invention provides for a device, system, and methods for using the same with kidney progenitor cells, specifically ureteric bud (UB) cells, metanephric mesenchymal (MM) cells, and the stromal cell (SC) subpopulation of the metanephric mesenchyme, to generate an embryonic kidney organoid that can be implanted into a mammalian subject to create a living, functional kidney.

Claims (33)

1. A method of generating an embryonic kidney organoid, the method comprising the steps of:

providing a kidney mold device having a ureteric bud (UB) cell chamber and a metanephric mesenchymal (MM) cell chamber, wherein the MM cell chamber is fluidly connected to the UB cell chamber;

providing a precursor micromold having a plurality of channels for generating a UB tube from UB cells, wherein the channels are dimensioned such that UB tubes formed in the channels fit within the UB cell chamber of the kidney mold device;

seeding UB cells into the precursor micromold to generate a UB tube;

transferring the UB tube into the kidney mold device UB cell chamber;

generating a metanephric mesenchymal/stromal cell (MM/SC) aggregate or suspension;

transferring the MM/SC aggregate or suspension into the kidney mold device MM cell chamber; and

culturing the kidney mold device in growth media to generate an embryonic kidney organoid.

2. The method of claim 1 , wherein said UB cell chamber is linearly shaped.

3. The method of claim 1 , wherein said MM cell chamber has the shape of an ellipse.

4. The method of claim 1 , wherein said MM cell chamber has the shape of a bulb.

5. The method of claim 1 , wherein said MM cell chamber has the shape of a circle.

6. The method of claim 1 , wherein said kidney mold device is formed from a hydrogel.

7. The method of claim 1 , wherein said kidney mold device is formed from a plastic polymer.

8. The method of claim 1 , wherein said UB cell chamber and said MM cell chamber are incorporated into a microfluidic device.

9. The method of claim 1 , wherein the kidney progenitor UB cells and MM/SC aggregate or suspension comprise embryonic cells differentiated towards the renal lineages of UB, MM, and stromal cells (SC).

10. The method of claim 1 , wherein the kidney progenitor UB cells and MM/SC aggregate or suspension comprise induced pluripotent stem cells differentiated towards the renal lineages of UB, MM, and SC.

11. The method of claim 1 , wherein the UB cells and MM/SC aggregate or suspension comprise urine derived stem cells differentiated towards the renal lineages of UB, MM, and SC.

12. The method of claim 1 , wherein the cells and MM/SC aggregate or suspension comprise amniotic fluid stem cells differentiated towards the renal lineages of UB, MM, and SC.

13. The method of claim 1 , further comprising the step of implanting said embryonic kidney organoid into a mammalian subject so that it can mature into a functional kidney.

14. The method of claim 13 , wherein said embryonic kidney organoid is a human embryonic kidney organoid.

15. The method of claim 1 , wherein the MM/SC are suspended in a medium selected from the group consisting of collagen, agarose, polyacrylamide, and matrigel.

16. The method of claim 1 , wherein the MM/SC are aggregated into a sphere by overnight culture or by centrifugation.

17. The method of claim 1 , wherein extracellular matrix (ECM) of an embryonic or adult kidney is added to the MM/SC aggregate or suspension.

18. A method of generating an embryonic kidney organoid, the method comprising the steps of:

providing a kidney mold device having a ureteric bud (UB) cell chamber and a metanephric mesenchymal (MM) cell chamber, wherein the MM cell chamber is fluidly connected to the UB cell chamber;

inserting a plug into the kidney mold device MM cell chamber;

seeding UB cells into the kidney mold device UB cell chamber to generate a UB tube;

removing the plug by extraction or dissolution;

generating a MM/somatic cell aggregate or suspension;

transferring the MM/somatic cell aggregate or suspension into the kidney mold device MM cell chamber; and

culturing the kidney mold device in growth media to generate an embryonic kidney organoid.

19. The method of claim 18 , wherein the plug comprises a dissolvable material selected from the group consisting of gelatin, hydrogel, and polymer.

Continuity (2)
Provisional Application 61945022 · Feb 26, 2014
Related Publication 20160361466A1 · Dec 15, 2016
Cited By (12)
US 12,241,090 US 12,258,584 US 12,281,334 US 12,297,457 US 12,371,669 US 12,379,372 US 12,414,967 US 12,421,500 US 12,428,622 US 12,497,597 US 12,534,709 US 12,600,943